 Myocardial protection Hamburg crystalloid cardioplegic solution multiple coronary bypass multivalvular replacement myocardial protection Hamburg crystalloid cardioplegic solution double study Part prospective metabolic study myocardial adenosine triphosphate ATP creatine phosphate CP contents ischemia coronary bypass CABG patients ischemia CP levels whereas minute reperfusion mean ATP contents preischemic values CP levels preischemic values Spontaneous myocardial defibrillation patients Part II evaluation early postischemic myocardial function patients multiple replacement MUVR CABG Spontaneous myocardial defibrillation Cardiac index hours surgery postischemic period l/min MUVR CABG Myocardial infarction frequency CABG patients unrelated number distal anastomosis cross-clamp time Early postoperative mortality MUVR CABG Thus cardioplegia Hamburg solution high-energy phosphate compounds prevents ischemic injury excellent short-term clinical results